ClinicalTrials.Veeva

Menu

The Acute Effects of Combined Caffeine and Sodium Bicarbonate Consumption on Isometric Mid-thigh Pull

B

Bozok University

Status

Completed

Conditions

Athletes

Treatments

Other: Baseline (Control)
Other: Performance-Enhancing Substances
Other: Placebo

Study type

Interventional

Funder types

Other

Identifiers

NCT05883046
BozokU-SBF-IK-01

Details and patient eligibility

About

The aim of this study was to investigate the effects of isolated and combined caffeine and sodium bicarbonate consumption on acute isometric mid-thigh pull (IMTP) strength, and verify whether they are cumulative, neutral or subtractive.

Full description

Method: Nineteen Sport Sciences Faculty students (Age 23.6±1.6 years, height 171±9.4 cm, weight 64.3±9.6 kg, fat percentage 20.5±7.3 %, BMI 21.7±2.4 kg/m2) participated and completed the intervention. This study was designed as crossover, double-blind and placebo-controlled. Subjects participated under 5 crossover conditions: control (without supplement) (Con), placebo (Pla), caffeine (Caf), sodium bicarbonate (NaHCO3) and caffeine+sodium bicarbonate (Caf+NaHCO3). For Caf conditions, participants consumed 6 mg/kg of caffeine, obtained from dosing the content of 200 mg capsules. As for NaHCO3 conditions, participants consumed 0.3 g/kg of sodium bicarbonate dissolved in water. For the combined condition, (Caf+NaHCO3), intake was set at 6 mg of caffeine and 0.3 g of sodium bicarbonate per kilogram of body weight. All supplements were consumed 60 min before the tests. Two submaximal trials of IMTP were performed at increasing intensities for 5 seconds (approximately %40-60 and %60-80 of their individually perceived 1RM, respectively, with 60-second rest intervals).

Enrollment

19 patients

Sex

All

Ages

18 to 24 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Being physically active and healthy
  • Did not use ergogenic supplements in the last 3 months
  • Did not consume high doses of caffeine (≤120-170 mg/d) were included in this study

Exclusion criteria

  • Actively using supplements
  • Did not perform maximal effort during performance tests
  • Not using the supplements in the correct dose or vomiting after use

Trial design

Primary purpose

Other

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

19 participants in 5 patient groups, including a placebo group

Baseline
Other group
Description:
The control measurement was made as a baseline measurement without supplementation
Treatment:
Other: Baseline (Control)
Placebo
Placebo Comparator group
Description:
During Placebo conditions, participants consumed 20gr of maltodextrin (European origin, Alfasol®, Kimbiotek, Turkey).
Treatment:
Other: Placebo
Caffeine
Experimental group
Description:
For Caffeine conditions, participants consumed 6 mg/kg of caffeine, obtained from dosing the content of 200 mg capsules (Nature's Supreme® Caffeine)
Treatment:
Other: Performance-Enhancing Substances
NaHCO3
Experimental group
Description:
As for NaHCO3 conditions, participants consumed 0.3 g/kg of sodium bicarbonate (Alfasol®, Kimbiotek, Turkey) dissolved in water
Treatment:
Other: Performance-Enhancing Substances
Combined
Experimental group
Description:
For the combined condition, (Caf+NaHCO3), 6 mg/kg of caffeine and 0.3 g/kg of sodium bicarbonate per kilogram of body weight of participants were consumed, after being dissolved together in water
Treatment:
Other: Performance-Enhancing Substances

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems